Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 32, 2013, Pages 13091-13096

  Bosurgi, Lidia ^a   Bernink, Jochem H ^a   Cuevas, Victor Delgado ^a   Gagliani, Nicola ^a   Joannas, Leonel ^a   Schmid, Edward T ^a   Booth, Carmen J ^a   Ghosh, Sourav ^b   Rothlin, Carla V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXL PROTEIN; AZOXYMETHANE; DEXTRAN SULFATE; MER PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; COLITIS; COLON CANCER; CYTOKINE PRODUCTION; DENDRITIC CELL; INFLAMMATION; LAMINA PROPRIA; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE;

ANIMALS; APOPTOSIS; AZOXYMETHANE; COLITIS; COLON; COLONIC NEOPLASMS; CYTOKINES; DEXTRAN SULFATE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; MACROPHAGES; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUCOUS MEMBRANE; NEUTROPHILS; PHAGOCYTOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84881426249     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1302507110     Document Type: Article

References (48)

1. Graham DK, Dawson TL, Mullaney DL, Snodgrass HR, Earp HS (1994) Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ 5(6):647-657.
2. O'Bryan JP, et al. (1991) axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11(10): 5016-5031.
3. Neubauer A, et al. (1993) Axl, a novel receptor tyrosine kinase isolated from chronic myelogenous leukemia. Semin Hematol 30(3, Suppl 3)34.
4. Linger RM, Keating AK, Earp HS, Graham DK (2010) Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets 14(10):1073-1090.
5. Linger RM, Keating AK, Earp HS, Graham DK (2008) TAM receptor tyrosine kinases: Biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 100:35-83.
6. Schlegel J, et al. (2013) MERTK receptor tyrosine kinase is a therapeutic target in melanoma. J Clin Invest 123(5):2257-2267.
7. Zhao Y, et al. (2012) Differential expression of Axl and correlation with invasion and multidrug resistance in cancer cells. Cancer Invest 30(4):287-294.
8. Hutterer M, et al. (2008) Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res 14(1):130-138.
9. Hector A, et al. (2010) The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma. Cancer Biol Ther 10(10): 1009-1018.
10. Byers LA, et al. (2013) An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 19:279-290.
11. Zhang Z, et al. (2012) Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nat Genet 44(8):852-860.
12. Paccez JD, et al. (2013) The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target. Oncogene 32(6):689-698.
13. Ou WB, et al. (2011) AXL regulates mesothelioma proliferation and invasiveness. Oncogene 30(14):1643-1652.
14. Song X, et al. (2011) Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer 117(4): 734-743.
15. Keating AK, et al. (2010) Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity. Mol Cancer Ther 9(5):1298-1307.
16. Verma A, Warner SL, Vankayalapati H, Bearss DJ, Sharma S (2011) Targeting Axl and Mer kinases in cancer. Mol Cancer Ther 10(10):1763-1773.
17. Mollard A, et al. (2011) Design, synthesis and biological evaluation of a series of novel Axl kinase inhibitors. ACS Med Chem Lett 2(12):907-912.
18. Holland SJ, et al. (2010) R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res 70(4):1544-1554.
19. Ye X, et al. (2010) An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies. Oncogene 29(38): 5254-5264.
20. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144 (5):646-674.
21. Terzic J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138(6):2101-2114.
22. Grivennikov SI, Karin M (2010) Inflammation and oncogenesis: A vicious connection. Curr Opin Genet Dev 20(1):65-71.
23. Soderlund S, et al. (2009) Decreasing time trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 136(5):1561-1567.
24. Ekbom A, Helmick C, ZackM, Adami HO (1990) Ulcerative colitis and colorectal cancer: A population-based study. N Engl J Med 323(18):1228-1233.
25. Grivennikov S, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15(2):103-113.
26. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G (2007) TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131(6):1124-1136.
27. Sharif MN, et al. (2006) Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 203(8):1891-1901.
28. Sen P, et al. (2007) Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 109(2):653-660.
29. Tibrewal N, et al. (2008) Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide- inducible NFkappaB transcriptional activation. J Biol Chem 283(6):3618-3627.
30. Wirtz S, Neufert C, Weigmann B, Neurath MF (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2(3):541-546.
31. De Robertis M, et al. (2011) The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog 10:9.
32. Lemke G, Rothlin CV (2008) Immunobiology of the TAM receptors. Nat Rev Immunol 8(5):327-336.
33. Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 27:451-483.
34. Hu B, et al. (2010) Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci USA 107(50):21635-21640.
35. O'Connor W, Jr., et al. (2009) A protective function for interleukin 17A in T cellmediated intestinal inflammation. Nat Immunol 10(6):603-609.
36. Hochreiter-Hufford A, Ravichandran KS (2013) Clearing the dead: Apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol 5(1): a008748.
37. Harhaj EW, Dixit VM (2012) Regulation of NF-κB by deubiquitinases. Immunol Rev 246(1):107-124.
38. Gautier EL, et al.; Immunological Genome Consortium (2012) Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 13(11):1118-1128.
39. Schulz C, et al. (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336(6077):86-90.
40. Ginhoux F, et al. (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330(6005):841-845.
41. Hashimoto D, et al. (2013) Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38(4):792-804.
42. Jenkins SJ, et al. (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332(6035):1284-1288.
43. Rothlin CV, Lemke G (2010) TAM receptor signaling and autoimmune disease. Curr Opin Immunol 22(6):740-746.
44. Zizzo G, Hilliard BA, Monestier M, Cohen PL (2012) Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 189(7):3508-3520.
45. Carrera A, et al. (2013) T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response. Immunity, 10.1016/ j.immuni.2013.06.010.
46. Chen MH, Kerkelä R, Force T (2008) Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Circulation 118(1):84-95.
47. Temming K, Fretz MM, Kok RJ (2008) Organ- and cell-type specific delivery of kinase inhibitors: A novel approach in the development of targeted drugs. Curr Mol Pharmacol 1(1):1-12.
48. Lu Q, et al. (1999) Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 398(6729):723-728.